InHANSE Institute of Head and Neck Studies and Education Contact Us


PET-CT guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer


PETNECK 2 logo for programme study


PETNECK 2 is a NIHR PgfAR funded Programme to develop a new way to follow-up patients, guided by their symptoms, and compare it to the current way. The new Patient-initiated follow-up method involves low risk head and neck cancer patients having a PET-CT scan 1 year after finishing treatment. If no cancer is detected, they will be educated, by a nurse, about what symptoms of recurrent cancer to look out for. The information will also be given in print and electronically (via a mobile App and website). An ‘open urgent appointment’ guarantees review by their clinical team within 2 weeks if they develop worrying symptoms, instead of regular clinic visits.

We will run a Feasibility study and Randomised Controlled Trial to compare this new Patient-Initiated Follow-up method with standard clinical follow-up to investigate:

1. Which is better at detecting cancer recurrence,

2. What effects these two ways have on patients’ experience, worry about recurrence and quality-of-life,

3. Which costs less, although this is not the main reason for running this study


Programme Manager:

Dr Saloni Mittal

Institute of Cancer and Genomic Sciences

Institute of Head and Neck Studies and Education (InHANSE)

Robert Aitken Building, 2nd Floor

University of Birmingham

Birmingham |B15 2TT



Charity appeal

Find out more about our £1m Charity appeal for the AcceleraTED cancer Treatment programme.